Literature DB >> 3445295

Chronic splenomegaly in Nairobi, Kenya. I. Epidemiology, malarial antibody and immunoglobulin levels.

K M De Cock1, A N Hodgen, S B Lucas, R A Jupp, B Slavin, T K Arap Siongok, P H Rees.   

Abstract

Chronic splenomegaly in 131 Kenyan patients was investigated at Kenyatta National Hospital, Nairobi. Patients were allocated to diagnostic groups on the basis of clinical, haematological, parasitological, histological, radiological and endoscopic data. The major diagnostic groups were hyper-reactive malarial splenomegaly, our preferred name for tropical splenomegaly syndrome, (31%), hepatosplenic schistosomiasis (18%), visceral leishmaniasis (5%) and "indeterminate splenomegaly", where no diagnosis could be reached (12%). Another 20% of patients were suffering from various non-schistosomal forms of portal hypertension. A number of specific and rarer causes accounted for the rest of the cases. The tribal and geographical distribution of patients with chronic splenomegaly was compared with the pattern of general medical admissions. Splenomegaly was more frequent than expected in Kamba and Luo patients. Hyper-reactive malarial splenomegaly and hepatosplenic schistosomiasis were common in both groups, whereas visceral leishmaniasis was almost restricted to the Kamba and indeterminate splenomegaly was especially prevalent in the Luo. Malarial antibody and immunoglobulin levels differed significantly between the various diagnostic categories of patients and controls. Malarial serology can be diagnostically useful for chronic splenomegaly, provided results are interpreted in their geographical context.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3445295     DOI: 10.1016/0035-9203(87)90296-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  6 in total

1.  Splenomegaly in 2,505 patients in a large university medical center from 1913 to 1995. 1913 to 1962: 2,056 patients.

Authors:  R A O'Reilly
Journal:  West J Med       Date:  1998-08

2.  Massive splenomegaly in rural Malawi: new wine, old wineskins and the importance of collaboration.

Authors:  Navin Venkatraman; Charlotte White; Joanne Haensel
Journal:  BMJ Case Rep       Date:  2014-07-04

Review 3.  Morbidity and mortality of portal hypertension.

Authors:  J B Ready; W G Rector
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 4.  The hyper-reactive malarial splenomegaly: a systematic review of the literature.

Authors:  Stefania Leoni; Dora Buonfrate; Andrea Angheben; Federico Gobbi; Zeno Bisoffi
Journal:  Malar J       Date:  2015-04-29       Impact factor: 2.979

5.  Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children.

Authors:  Mark Booth; Birgitte J Vennervald; Anthony E Butterworth; Henry C Kariuki; Clifford Amaganga; Gachuhi Kimani; Joseph K Mwatha; Amos Otedo; John H Ouma; David W Dunne
Journal:  BMC Med       Date:  2004-09-27       Impact factor: 8.775

6.  Treatment of suspected hyper-reactive malarial splenomegaly (HMS) in pregnancy with mefloquine.

Authors:  Juthamas Jaroensuk; Nicole Stoesser; Mara L Leimanis; Podjanee Jittamala; Nicholas J White; Francois H Nosten; Rose McGready
Journal:  Am J Trop Med Hyg       Date:  2014-03-03       Impact factor: 2.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.